Prevalence and incidence of metabolic syndrome in people with HIV receiving cabotegravir and rilpivirine. Ranzenigo M, Diotallevi S, Lolatto R, Castagna A, et al. J Acquir Immune Defic Syndr 2025 Jun 20. doi: 10.1097/QAI.0000000000003719.

Read + Share

Amedeo Smart

Independent Medical Education

Ranzenigo M, Diotallevi S, Lolatto R, Castagna A, et al. Prevalence and incidence of metabolic syndrome in people with HIV receiving cabotegravir and rilpivirine. J Acquir Immune Defic Syndr 2025 Jun 20. doi: 10.1097/QAI.0000000000003719.
PMID: 40539800